Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Heart Failure

  Free Subscription

Articles published in Heart

Retrieve available abstracts of 190 articles:
HTML format

Single Articles

    March 2021
  1. ROMAINE SPR, Denniff M, Codd V, Nath M, et al
    Telomere length is independently associated with all-cause mortality in chronic heart failure.
    Heart. 2021 Mar 31. pii: heartjnl-2020-318654. doi: 10.1136/heartjnl-2020-318654
    PubMed     Abstract available

    Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closer.
    Heart. 2021 Mar 18. pii: heartjnl-2021-319153. doi: 10.1136/heartjnl-2021-319153

  3. AIMO A, Prontera C, Passino C, Emdin M, et al
    Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318791. doi: 10.1136/heartjnl-2020-318791
    PubMed     Abstract available

  4. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    PubMed     Abstract available

  5. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    PubMed     Abstract available

    February 2021
  6. JOSHI SS, Singh T, Newby DE, Singh J, et al
    Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021 Feb 26. pii: heartjnl-2020-318060. doi: 10.1136/heartjnl-2020-318060
    PubMed     Abstract available

    Heart failure in adults with congenital heart disease: a call for action.
    Heart. 2021 Feb 23. pii: heartjnl-2020-318757. doi: 10.1136/heartjnl-2020-318757

  8. NISHIKAWA Y, Fukahori H, Mizuno A, Kwong JS, et al
    Cochrane corner: advance care planning for adults with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-318458. doi: 10.1136/heartjnl-2020-318458

  9. YAMAMOTO S, Yamaga T, Kawachi S, Shibuya M, et al
    Cochrane corner: Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-317888. doi: 10.1136/heartjnl-2020-317888

    January 2021
  10. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available

  11. MOHEBALI D, Kittleson MM
    Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318062. doi: 10.1136/heartjnl-2020-318062
    PubMed     Abstract available

  12. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available

  13. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Response to 'Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction'.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318849. doi: 10.1136/heartjnl-2020-318849.

  14. ALBUQUERQUE LL, Meira E Cruz M, Salles C
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318762. doi: 10.1136/heartjnl-2020-318762.

    December 2020
  15. BLACHER M, Zimerman A, Engster PHB, Grespan E, et al
    Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II.
    Heart. 2020 Dec 23. pii: heartjnl-2020-317984. doi: 10.1136/heartjnl-2020-317984
    PubMed     Abstract available

  16. BURSTEIN DS, Rossano JW, Griffis H, Zhang X, et al
    Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318246. doi: 10.1136/heartjnl-2020-318246
    PubMed     Abstract available

    November 2020
  17. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    PubMed     Abstract available

  18. REARDON L, Lin J
    Advanced heart failure and transplant in congenital heart disease.
    Heart. 2020 Nov 13. pii: heartjnl-2019-316366. doi: 10.1136/heartjnl-2019-316366

  19. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2020 Nov 6. pii: heartjnl-2020-317326. doi: 10.1136/heartjnl-2020-317326.
    PubMed     Abstract available

  20. DROZD M, Relton SD, Walker AMN, Slater TA, et al
    Association of heart failure and its comorbidities with loss of life expectancy.
    Heart. 2020 Nov 5. pii: heartjnl-2020-317833. doi: 10.1136/heartjnl-2020-317833.
    PubMed     Abstract available

  21. ZIMERMAN A, Rohde LE
    Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure.
    Heart. 2020 Nov 2. pii: heartjnl-2020-317977. doi: 10.1136/heartjnl-2020-317977.

    October 2020
  22. HUNG CL, Chao TF, Su CH, Liao JN, et al
    Income level and outcomes in patients with heart failure with universal health coverage.
    Heart. 2020 Oct 20. pii: heartjnl-2020-316793. doi: 10.1136/heartjnl-2020-316793
    PubMed     Abstract available

  23. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available

  24. BHATIA HS, Nishimura M, Dickson S, Adler E, et al
    Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.
    Heart. 2020 Oct 5. pii: heartjnl-2020-317635. doi: 10.1136/heartjnl-2020-317635.
    PubMed     Abstract available

    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.

  26. MOCERI P, Lopez S, Ferrari E
    Atypical right heart failure in a septuagenarian.
    Heart. 2020;106:1524-1536.

    September 2020
  27. BERGLUND F, Pina P, Herrera CJ
    Right ventricle in heart failure with preserved ejection fraction.
    Heart. 2020 Sep 7. pii: heartjnl-2020-317342. doi: 10.1136/heartjnl-2020-317342.
    PubMed     Abstract available

    August 2020
  28. PERRY AS, Mann DL, Brown DL
    Improvement of ejection fraction and mortality in ischaemic heart failure.
    Heart. 2020 Aug 25. pii: heartjnl-2020-316975. doi: 10.1136/heartjnl-2020-316975
    PubMed     Abstract available

  29. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available

  30. SCHRAGE B, Lund LH, Benson L, Stolfo D, et al
    Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure.
    Heart. 2020 Aug 7. pii: heartjnl-2020-317216. doi: 10.1136/heartjnl-2020-317216.
    PubMed     Abstract available

    July 2020
    NICE heart failure guidelines: the diagnostic algorithm in practice, what is the next step?
    Heart. 2020 Jul 20. pii: heartjnl-2020-317450. doi: 10.1136/heartjnl-2020-317450

  32. ZHENG A, Cowan E, Mach L, Adam RD, et al
    Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance.
    Heart. 2020 Jul 20. pii: heartjnl-2019-316511. doi: 10.1136/heartjnl-2019-316511
    PubMed     Abstract available

  33. DARDAS T, Dorsch MP
    Remote management of heart failure: Herculean or Sisyphean task?
    Heart. 2020 Jul 9. pii: heartjnl-2020-317270. doi: 10.1136/heartjnl-2020-317270.

    June 2020
  34. RAHIMI K, Nazarzadeh M, Pinho-Gomes AC, Woodward M, et al
    Home monitoring with technology-supported management in chronic heart failure: a randomised trial.
    Heart. 2020 Jun 24. pii: heartjnl-2020-316773. doi: 10.1136/heartjnl-2020-316773
    PubMed     Abstract available

  35. MARINI C, Fragasso G, Italia L, Sisakian H, et al
    Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure.
    Heart. 2020 Jun 22. pii: heartjnl-2019-316429. doi: 10.1136/heartjnl-2019-316429
    PubMed     Abstract available

  36. ROSANO G, Savarese G
    Inter-twinned relationship between heart failure and atrial fibrillation.
    Heart. 2020 Jun 1. pii: heartjnl-2020-316886. doi: 10.1136/heartjnl-2020-316886.

    April 2020
  37. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available

  38. HONG SH, Lee JS, Kim JA, Lee YB, et al
    Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316271. doi: 10.1136/heartjnl-2019-316271
    PubMed     Abstract available

  39. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.

    March 2020
  40. OTTO CM
    Heartbeat: can machine learning improve outcomes in patients with heart failure with preserved ejection fraction?
    Heart. 2020;106:315-317.

  41. CHEN S, Banerjee A
    Machine learning: a long way from implementation in cardiovascular disease.
    Heart. 2020;106:318-320.

    February 2020
  42. ERGATOUDES C, Hansson PO, Svardsudd K, Rosengren A, et al
    Comparison of incidence rates and risk factors of heart failure between two male cohorts born 30 years apart.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316059. doi: 10.1136/heartjnl-2019-316059
    PubMed     Abstract available

  43. CHEHAB O, Roberts-Thomson R, Ng Yin Ling C, Marber M, et al
    Secondary mitral regurgitation: pathophysiology, proportionality and prognosis.
    Heart. 2020 Feb 13. pii: heartjnl-2019-316238. doi: 10.1136/heartjnl-2019-316238
    PubMed     Abstract available

    Ethnicity, heart failure and the prevention continuum: time to act.
    Heart. 2020 Feb 6. pii: heartjnl-2019-316293. doi: 10.1136/heartjnl-2019-316293.

  45. BEGUE C, Morner S, Brito D, Hengstenberg C, et al
    Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Heart. 2020;106:196-202.
    PubMed     Abstract available

  46. TOBLER D, Greutmann M
    Simple cardiac shunts in adults: atrial septal defects, ventricular septal defects, patent ductus arteriosus.
    Heart. 2020;106:307-314.

  47. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.

    January 2020
  48. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957

  49. HEDMAN AK, Hage C, Sharma A, Brosnan MJ, et al
    Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
    Heart. 2020 Jan 7. pii: heartjnl-2019-315481. doi: 10.1136/heartjnl-2019-315481.
    PubMed     Abstract available

  50. GALLEGO P, Oliver JM
    Medical therapy for heart failure in adult congenital heart disease: does it work?
    Heart. 2020;106:154-162.

    December 2019
  51. UEBERHAM L, Konig S, Hohenstein S, Mueller-Roething R, et al
    Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315566. doi: 10.1136/heartjnl-2019-315566
    PubMed     Abstract available

  52. OSTERGAARD L, Dahl A, Bruun NE, Oestergaard LB, et al
    Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-315715. doi: 10.1136/heartjnl-2019-315715
    PubMed     Abstract available

  53. WOOD K, Gladwin M, Straub A
    Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-314810. doi: 10.1136/heartjnl-2019-314810
    PubMed     Abstract available

    October 2019
  54. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Abstract available

  55. OTTO CM
    Heartbeat: oxygen transport close to and far from the ventricle in heart failure.
    Heart. 2019;105:1525-1527.

    September 2019
  56. MAHAJAN R, Stokes M, Elliott A, Munawar DA, et al
    Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis.
    Heart. 2019 Sep 17. pii: heartjnl-2019-314770. doi: 10.1136/heartjnl-2019-314770
    PubMed     Abstract available

  57. AHN MS, Yoo BS, Yoon J, Lee SH, et al
    Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315240. doi: 10.1136/heartjnl-2019-315240.
    PubMed     Abstract available

  58. BERNARD S, Hung J
    Managing tricuspid valve regurgitation: a long and winding road.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315696. doi: 10.1136/heartjnl-2019-315696.

    August 2019
  59. RODRIGUES BS, David C, Costa J, Ferreira JJ, et al
    Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315193. doi: 10.1136/heartjnl-2019-315193
    PubMed     Abstract available

  60. REDDY YNV, Nishimura R
    Intervening for tricuspid regurgitation: uncertainties in a heterogeneous syndrome.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315624. doi: 10.1136/heartjnl-2019-315624

  61. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    PubMed     Abstract available

  62. KADRI AN, Menon V, Sammour YM, Gajulapalli RD, et al
    Outcomes of patients with severe tricuspid regurgitation and congestive heart failure.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315004. doi: 10.1136/heartjnl-2019-315004
    PubMed     Abstract available

  63. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Abstract available

    July 2019
  64. SILLARS A, Ho FK, Pell GP, Gill JMR, et al
    Sex differences in the association of risk factors for heart failure incidence and mortality.
    Heart. 2019 Jul 31. pii: heartjnl-2019-314878. doi: 10.1136/heartjnl-2019-314878
    PubMed     Abstract available

  65. WANG F, Harel-Sterling L, Cohen S, Liu A, et al
    Heart failure risk predictions in adult patients with congenital heart disease: a systematic review.
    Heart. 2019 Jul 26. pii: heartjnl-2019-314977. doi: 10.1136/heartjnl-2019-314977
    PubMed     Abstract available

  66. LUMBERS RT, Martin N, Manoharan K, Thomas J, et al
    Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
    Heart. 2019 Jul 25. pii: heartjnl-2018-313855. doi: 10.1136/heartjnl-2018-313855

  67. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    PubMed     Abstract available

  68. CROSSLAND DS, Jansen K, Parry G, Harper A, et al
    Outcome following heart transplant assessment in adults with congenital heart disease.
    Heart. 2019 Jul 5. pii: heartjnl-2019-314711. doi: 10.1136/heartjnl-2019-314711.
    PubMed     Abstract available

    June 2019
  69. HEARON CM JR, Sarma S, Dias KA, Hieda M, et al
    Impaired oxygen uptake kinetics in heart failure with preserved ejection fraction.
    Heart. 2019 Jun 17. pii: heartjnl-2019-314797. doi: 10.1136/heartjnl-2019-314797
    PubMed     Abstract available

  70. CLARK AL, Kalra PR, Petrie MC, Mark PB, et al
    Change in renal function associated with drug treatment in heart failure: national guidance.
    Heart. 2019;105:904-910.
    PubMed     Abstract available

  71. TAN ESJ, Tay WT, Teng TK, Richards AM, et al
    The diabetes-atrial fibrillation paradox.
    Heart. 2019;105:893.

  72. GERDTS E, Saeed S, Midtbo H, Rossebo A, et al
    Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis.
    Heart. 2019 Jun 1. pii: heartjnl-2018-314462. doi: 10.1136/heartjnl-2018-314462.
    PubMed     Abstract available

    May 2019
  73. ONG G, Pibarot P
    Combined aortic stenosis and regurgitation: double the trouble.
    Heart. 2019 May 29. pii: heartjnl-2017-312303. doi: 10.1136/heartjnl-2017-312303

  74. SCHICHTEL M, Wee B, Perera R, Onakpoya I, et al
    Clinician-targeted interventions to improve advance care planning in heart failure: a systematic review and meta-analysis.
    Heart. 2019 May 22. pii: heartjnl-2019-314758. doi: 10.1136/heartjnl-2019-314758
    PubMed     Abstract available

  75. OTTO CM
    Heartbeat: Primary care delays in heart failure diagnosis.
    Heart. 2019;105:661-662.

    April 2019
  76. SALAH K, Stienen S, Pinto YM, Eurlings LW, et al
    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314173. doi: 10.1136/heartjnl-2018-314173.
    PubMed     Abstract available

  77. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    PubMed     Abstract available

  78. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    PubMed     Abstract available

    March 2019
  79. CHRISTIANSEN MN, Kober L, Torp-Pedersen C, Smith JG, et al
    Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.
    Heart. 2019 Mar 25. pii: heartjnl-2018-314552. doi: 10.1136/heartjnl-2018-314552
    PubMed     Abstract available

  80. ANDERSON LJ, Squire IB, Cowie MR
    Global lessons from deaths from heart failure in UK hospitals.
    Heart. 2019 Mar 2. pii: heartjnl-2018-314641. doi: 10.1136/heartjnl-2018-314641.

    February 2019
  81. FROHLICH H, Rosenfeld N, Tager T, Goode K, et al
    Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Heart. 2019 Feb 21. pii: heartjnl-2018-314256. doi: 10.1136/heartjnl-2018-314256
    PubMed     Abstract available

  82. BURDEN AF, Timpson N
    Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
    Heart. 2019 Feb 6. pii: heartjnl-2018-314467. doi: 10.1136/heartjnl-2018-314467.

  83. Correction: Heart rate: surrogate or target in the management of heart failure?
    Heart. 2019;105:e1.

    January 2019
    Creating order out of chaos: quality of care in heart failure.
    Heart. 2019 Jan 31. pii: heartjnl-2018-314526. doi: 10.1136/heartjnl-2018-314526

  85. AGARWAL A, Bahiru E, Yoo SGK, Berendsen MA, et al
    Hospital-based quality improvement interventions for patients with heart failure: a systematic review.
    Heart. 2019 Jan 30. pii: heartjnl-2018-314129. doi: 10.1136/heartjnl-2018-314129
    PubMed     Abstract available

  86. PINHO-GOMES AC, Rahimi K
    Management of blood pressure in heart failure.
    Heart. 2019 Jan 23. pii: heartjnl-2018-314438. doi: 10.1136/heartjnl-2018-314438
    PubMed     Abstract available

  87. TAN ESJ, Tay WT, Teng TK, Sim D, et al
    Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314077. doi: 10.1136/heartjnl-2018-314077
    PubMed     Abstract available

    Diagnosing heart failure: challenges in primary care.
    Heart. 2019 Jan 15. pii: heartjnl-2018-314396. doi: 10.1136/heartjnl-2018-314396

  89. DIMOPOULOS K, Muthiah K, Alonso-Gonzalez R, Banner NR, et al
    Heart or heart-lung transplantation for patients with congenital heart disease in England.
    Heart. 2019 Jan 12. pii: heartjnl-2018-313984. doi: 10.1136/heartjnl-2018-313984
    PubMed     Abstract available

  90. OTTO CM
    Heartbeat: heart failure induced by cancer therapy.
    Heart. 2019;105:1-3.

    December 2018
  91. NAKATSUMA K, Taniguchi T, Morimoto T, Shiomi H, et al
    B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
    Heart. 2018 Dec 7. pii: heartjnl-2018-313746. doi: 10.1136/heartjnl-2018-313746.
    PubMed     Abstract available

  92. HAYHOE B, Kim D, Aylin PP, Majeed FA, et al
    Adherence to guidelines in management of symptoms suggestive of heart failure in primary care.
    Heart. 2018 Dec 4. pii: heartjnl-2018-313971. doi: 10.1136/heartjnl-2018-313971.
    PubMed     Abstract available

  93. DEFARIA YEH D, Stefanescu Schmidt AC, Eisman AS, Serfas JD, et al
    Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease.
    Heart. 2018;104:2044-2050.
    PubMed     Abstract available

    October 2018
  94. AL RIFAI M, Blaha MJ, Rahman F, Ehrman JK, et al
    Inverse association of pulse pressure augmentation during exercise with heart failure and death.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313736. doi: 10.1136/heartjnl-2018-313736
    PubMed     Abstract available

  95. MILANI GP, Bianchetti MG, Lava SA
    Measurement of sodium in heart failure.
    Heart. 2018;104:1724.

  96. BUBER J, Valente AM
    Predicting survival in adults with congenital heart disease: what are the odds?
    Heart. 2018;104:1643-1644.

    September 2018
  97. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Abstract available

  98. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Abstract available

  99. BHAGRA SK, Pettit S, Parameshwar J
    Cardiac transplantation: indications, eligibility and current outcomes.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313103. doi: 10.1136/heartjnl-2018-313103

  100. DIBBEN GO, Dalal HM, Taylor RS, Doherty P, et al
    Cardiac rehabilitation and physical activity: systematic review and meta-analysis.
    Heart. 2018;104:1394-1402.
    PubMed     Abstract available

  101. KRUPICKOVA S, Morgan GJ, Cheang MH, Rigby ML, et al
    Symptomatic partial and transitional atrioventricular septal defect repaired in infancy.
    Heart. 2018;104:1411-1416.
    PubMed     Abstract available

    August 2018
  102. SZE S, Pellicori P, Zhang J, Clark AL, et al
    Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313312. doi: 10.1136/heartjnl-2018-313312
    PubMed     Abstract available

  103. WOLFSON AM, Fong M, Grazette L, Rahman JE, et al
    Chronic heart failure management and remote haemodynamic monitoring.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313397. doi: 10.1136/heartjnl-2018-313397
    PubMed     Abstract available

  104. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Abstract available

  105. SULTAN I, Cardounel A, Abdelkarim I, Kilic A, et al
    Right ventricle to pulmonary artery coupling in patients undergoing transcatheter aortic valve implantation.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313385. doi: 10.1136/heartjnl-2018-313385.
    PubMed     Abstract available

  106. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    PubMed     Abstract available

  107. CHOUSOU PA, Pugh PJ
    How to deliver optimal cardiac resynchronisation therapy.
    Heart. 2018;104:1300-1307.

    July 2018
  108. PRASAD SB, Holland DJ, Atherton JJ
    Diastolic stress echocardiography: from basic principles to clinical applications.
    Heart. 2018 Jul 20. pii: heartjnl-2017-312323. doi: 10.1136/heartjnl-2017-312323
    PubMed     Abstract available

  109. LYON AR
    Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.
    Heart. 2018 Jul 4. pii: heartjnl-2018-313493. doi: 10.1136/heartjnl-2018-313493.

  110. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.

  111. NANCHEN D
    Resting heart rate: what is normal?
    Heart. 2018;104:1048-1049.

  112. JARVIE JL, Metz TD, Davis MB, Ehrig JC, et al
    Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.
    Heart. 2018;104:1187-1194.
    PubMed     Abstract available

    June 2018
  113. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.

  114. ZHU K, Knuiman M, Divitini M, Murray K, et al
    High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Heart. 2018;104:895-903.
    PubMed     Abstract available

  115. FRANCIS R, Lewis C
    Myocardial biopsy: techniques and indications.
    Heart. 2018;104:950-958.

    May 2018
  116. NG AT, Duan L, Win T, Spencer HT, et al
    Maternal and fetal outcomes in pregnant women with heart failure.
    Heart. 2018 May 25. pii: heartjnl-2018-313156. doi: 10.1136/heartjnl-2018-313156
    PubMed     Abstract available

  117. NADRUZ W JR, West E, Sengelov M, Grove GL, et al
    Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.
    Heart. 2018 May 15. pii: heartjnl-2018-313234. doi: 10.1136/heartjnl-2018-313234
    PubMed     Abstract available

    April 2018
  118. APPS A, Lau J, Peterzan M, Neubauer S, et al
    Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging.
    Heart. 2018 Apr 27. pii: heartjnl-2017-312356. doi: 10.1136/heartjnl-2017-312356
    PubMed     Abstract available

  119. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Abstract available

  120. ROHDE LE, Beck-da-Silva L
    Alcohol and the heart: the good, the bad and the worse in heart failure.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312924. doi: 10.1136/heartjnl-2017-312924.

  121. GUPTA D, Masoud A, Bartoletti S
    The Authors' reply.
    Heart. 2018;104:626.

  122. OTTO CM
    Heartbeat: phenotypic heterogeneity of bicuspid aortic valve disease.
    Heart. 2018;104:541-543.

    March 2018
  123. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Abstract available

  124. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910

  125. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Abstract available

  126. NADRUZ W JR, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, et al
    Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Heart. 2018 Mar 9. pii: heartjnl-2017-312869. doi: 10.1136/heartjnl-2017-312869.
    PubMed     Abstract available

  127. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.

  128. WAGNER F, Gebauer RA, Paech C
    Newborn in cardiogenic shock.
    Heart. 2018;104:467.
    PubMed     Abstract available

    February 2018
  129. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.

  130. WILSON AJ, Gill EK, Abudalo RA, Edgar KS, et al
    Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Heart. 2018;104:293-299.
    PubMed     Abstract available

    January 2018
  131. WITTE KK, Patel PA, Walker AMN, Schechter CB, et al
    Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.
    Heart. 2018 Jan 31. pii: heartjnl-2017-312539. doi: 10.1136/heartjnl-2017-312539
    PubMed     Abstract available

  132. SQUIRE I
    Socioeconomic status and outcomes in heart failure with reduced ejection fraction.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312814. doi: 10.1136/heartjnl-2017-312814

  133. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Abstract available

  134. WANG YC, Huang CW, Lin TW
    Acute heart failure with new-onset continuous murmur in a 26-year-old man.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312506. doi: 10.1136/heartjnl-2017-312506
    PubMed     Abstract available

  135. ZAKERI R, Cowie MR
    Heart failure with preserved ejection fraction: controversies, challenges and future directions.
    Heart. 2018 Jan 5. pii: heartjnl-2016-310790. doi: 10.1136/heartjnl-2016-310790.
    PubMed     Abstract available

    Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?
    Heart. 2018;104:88-89.

  137. NATHANIA M, Hollingsworth KG, Bates M, Eggett C, et al
    Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women.
    Heart. 2018;104:111-118.
    PubMed     Abstract available

    December 2017
  138. MCMURRAY JJV, Trueman D, Hancock E, Cowie MR, et al
    Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
    Heart. 2017 Dec 21. pii: heartjnl-2016-310661. doi: 10.1136/heartjnl-2016-310661
    PubMed     Abstract available

  139. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Abstract available

  140. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Abstract available

  141. RAO P, Faddis M
    Cardiac resynchronisation therapy: current indications, management and basic troubleshooting.
    Heart. 2017;103:2000-2007.

    November 2017
  142. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Abstract available

  143. MORTON G, Masters J, Cowburn PJ
    Multidisciplinary team approach to heart failure management.
    Heart. 2017 Nov 23. pii: heartjnl-2016-310598. doi: 10.1136/heartjnl-2016-310598

  144. HUTCHINGS DC, Anderson SG, Trafford AW
    Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Heart. 2017;103:1745.

    October 2017
  145. LEE H, Lee SE, Park CS, Park JJ, et al
    Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction.
    Heart. 2017 Oct 27. pii: heartjnl-2017-312084. doi: 10.1136/heartjnl-2017-312084
    PubMed     Abstract available

  146. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Heart. 2017 Oct 5. pii: heartjnl-2017-311813. doi: 10.1136/heartjnl-2017-311813.
    PubMed     Abstract available

  147. BOTTLE A, Kim D, Aylin P, Cowie MR, et al
    Routes to diagnosis of heart failure: observational study using linked data in England.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312183. doi: 10.1136/heartjnl-2017-312183.
    PubMed     Abstract available

  148. PETRIE MC, Rocchiccioli P
    Coronary angiography in heart failure: when and why? Uncertainty reigns.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312200. doi: 10.1136/heartjnl-2017-312200.

  149. SINGH JSS, Burrell LM, Cherif M, Squire IB, et al
    Sacubitril/valsartan: beyond natriuretic peptides.
    Heart. 2017;103:1569-1577.
    PubMed     Abstract available

  150. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Abstract available

    August 2017
  151. SCHNELL F, Donal E
    Pharmacological strategies in heart failure with preserved ejection fraction: time for an individualised treatment strategy?
    Heart. 2017 Aug 18. pii: heartjnl-2017-312119. doi: 10.1136/heartjnl-2017-312119

  152. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    PubMed     Abstract available

  153. ZHENG SL, Chan FT, Nabeebaccus AA, Shah AM, et al
    Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311652. doi: 10.1136/heartjnl-2017-311652.
    PubMed     Abstract available

    July 2017
  154. TUEGEL C, Bansal N
    Heart failure in patients with kidney disease.
    Heart. 2017 Jul 17. pii: heartjnl-2016-310794. doi: 10.1136/heartjnl-2016-310794
    PubMed     Abstract available

  155. SCHMIDT M
    Interaction between body mass index and physical fitness in primary heart failure prevention.
    Heart. 2017 Jul 17. pii: heartjnl-2017-311504. doi: 10.1136/heartjnl-2017-311504

  156. MINAMINO-MUTA E, Kato T, Morimoto T, Taniguchi T, et al
    Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
    Heart. 2017 Jul 6. pii: heartjnl-2016-311022. doi: 10.1136/heartjnl-2016-311022.
    PubMed     Abstract available

  157. D'AMARIO D, Amodeo A, Adorisio R, Tiziano FD, et al
    A current approach to heart failure in Duchenne muscular dystrophy.
    Heart. 2017 Jul 1. pii: heartjnl-2017-311269. doi: 10.1136/heartjnl-2017-311269.
    PubMed     Abstract available

  158. GROGAN M, Dispenzieri A, Gertz MA
    Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Heart. 2017;103:1065-1072.
    PubMed     Abstract available

    June 2017
  159. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684

  160. ROHDE LE, Biolo A
    The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure.
    Heart. 2017 Jun 5. pii: heartjnl-2017-311558. doi: 10.1136/heartjnl-2017-311558.

    May 2017
  161. CRUMP C, Sundquist J, Winkleby MA, Sundquist K, et al
    Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
    Heart. 2017 May 12. pii: heartjnl-2016-310716. doi: 10.1136/heartjnl-2016-310716
    PubMed     Abstract available

  162. CARLSON S, Duber HC, Achan J, Ikilezi G, et al
    Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
    Heart. 2017 May 10. pii: heartjnl-2016-310913. doi: 10.1136/heartjnl-2016-310913
    PubMed     Abstract available

  163. KUTYIFA V
    Gender-specific outcomes of cardiac resynchronisation therapy with or without defibrillator.
    Heart. 2017;103:732-733.

  164. OTTO CM
    Heartbeat: Cardiac resynchronization therapy with or without defibrillation: are women different?
    Heart. 2017;103:727-728.

    April 2017
  165. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Abstract available

    March 2017
  166. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.

  167. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.

    February 2017
  168. ROSMINI S, Biagini E, O'Mahony C, Bulluck H, et al
    Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Heart. 2017;103:300-306.
    PubMed     Abstract available

    January 2017
  169. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    PubMed     Abstract available

    December 2016
  170. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    PubMed     Abstract available

  171. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    PubMed     Abstract available

  172. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.

    Heart transplantation in adult congenital heart disease.
    Heart. 2016;102:1871-1877.
    PubMed     Abstract available

    November 2016
  174. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191

    October 2016
  175. CHIMURA M, Onishi T, Tsukishiro Y, Sawada T, et al
    Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Heart. 2016 Oct 31. pii: heartjnl-2016-309746. doi: 10.1136/heartjnl-2016-309746
    PubMed     Abstract available

  176. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039

  177. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536

  178. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Abstract available

  179. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Abstract available

    September 2016
  180. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336

  181. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Abstract available

  182. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    PubMed     Abstract available

  183. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    PubMed     Abstract available

  184. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Abstract available

  185. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    PubMed     Abstract available

  186. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    PubMed     Abstract available

    June 2016
  187. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Abstract available

    February 2016
  188. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.

  189. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.

    December 2015
  190. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.